Shohei Ohtani will miss his July 22 pitching start against the Philadelphia Phillies due to ongoing left knee irritation, casting doubt on his return to the mound this season. Instead, the Los Angeles Dodgers will utilize him solely as a designated hitter while he undergoes medical treatments, including fluid drainage and potential injections aimed at recovery.
This absence from pitching impacts more than just game-day rotations. Market confidence in Ohtani's ability to maintain his unique two-way player value has weakened, reflecting a drop in his MVP prospects. The Dodgers must now reconsider their rotation strategy without one of their most versatile assets.
Investors and analysts monitoring Ohtani's status are watching for clear updates from the Dodgers, as any information on his pitching timeline could significantly influence expectations and market pricing for his overall performance this season. on top of that, his role as a designated hitter alone may alter perceptions of his contribution to the team’s success and his individual accolades.
